Viewing nowCombinationTeramofin Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea United Pharm Co., Ltd.

MFDS item code 201700389 · Approved 2017.01.20 · Insurance code 644309120
Improvement in blood pressure control for essential hypertension
This medication helps to lower blood pressure more effectively in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either telmisartan or amlodipine. This helps to reduce the risk of cardiovascular disease associated with hypertension and maintain healthy vascular status. It is used to improve blood pressure management in patients and enhance overall cardiovascular health.
The recommended dose of this medication is 1 tablet once daily, taken with water regardless of meals. It is advised to take it at the same time each day (e.g., in the morning) if possible. If blood pressure is not controlled, doses of 40/5 mg, 80/5 mg, 40/10 mg, or 80/10 mg may be used for adjustments, and dosage modifications may be needed according to renal impairment, liver impairment, or age.
Safety and efficacy in pediatric patients under 18 years of age have not been established, so the use of this medication is not recommended.
This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters, and should not be used by pregnant women or women who may become pregnant. Patients with allergies to this drug's active ingredients or similar components, breastfeeding women, and patients with severely impaired liver or heart function should not take this medication. Caution should be exercised when administering this medication to patients with impaired liver or kidney function, those with heart valve disease, or those with active gastrointestinal disease, and dosage adjustments may be necessary based on physician instructions. Common side effects include dizziness and peripheral edema, and serious side effects may occur infrequently. Therefore, if unusual symptoms appear, immediate consultation with healthcare professionals is required. There may be occasions when blood pressure drops too low, so if symptoms of hypotension occur, the patient should lie down, and if necessary, receive intravenous fluids. While treatment does not need to be discontinued, caution is advised. During therapy with this medication, it is important to regularly monitor serum potassium levels and kidney function to detect hyperkalemia or deterioration of renal function early. When taken with other antihypertensive agents, diuretics, potassium supplements, etc., potential interactions may occur, so patients must inform their doctor or pharmacist and take this medication with care. This medication may affect sleep or concentration, therefore caution should be taken when driving or operating hazardous machinery during treatment. In case of overdose, severe hypotension, dizziness, and cardiac arrhythmias may occur, so patients should be careful not to exceed the prescribed dosage and seek immediate medical attention if unusual symptoms arise. In children or the elderly, use of this medication may be restricted or dose adjustments may be required, so it is essential to follow the appropriate dosing guidelines for the respective age group. This medication should be stored sealed to prevent moisture and kept in a safe place out of the reach of children.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning-type headache, seizures, confusion, visual disturbances, paralysis.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication. Proper storage will help maintain its effectiveness.
A white and light blue bilayer oval tablet that is convex on both sides.
30 tablets/box [30 tablets (10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea United Pharm Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.